KWC/H Knowlton Capital

LGC Capital Grants Stock Options

LGC Capital Grants Stock Options

MONTREAL, April 05, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (the “Corporation” or “LGC”) (TSXV:LG) (OTCQB:LGGCF) announces that it has granted stock options to purchase a total of 6,100,000 common shares of the Corporation to certain new executive officers.  All of these options are exercisable at a price of $0.13 per share and have a term of five years. The options are subject in all respects to the terms of LGC’s stock option plan, the requirements of the TSX Venture Exchange and shareholder approval.

About LGC Capital

LGC is a leading cannabis investment firm with a focus on the Legal Global Cannabis market.  Through its growing portfolio investment companies, LGC is building a vertically integrated system of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets. LGC is a Canadian incorporated public company listed on the TSX Venture Exchange.

Through its partners and assuming pending transactions under review by the TSXV are approved, LGC presently will have interests in over 450,000 square feet of planted cannabis in Jamaica, Switzerland, Italy, and Australia. That is expected to increase to over 2,100,000 square feet by 2021, as its portfolio companies execute their expansion plans, in addition to the anticipated licensing of Tricho-Med’s operations in Quebec, Canada.

LGC partners currently sell cannabis products in over 1,000 points of sale across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands as well as medical cannabis oils in Australia under the Little Green Pharma brand. LGC’s partners’ branded products are available in a variety of formats including dry cannabis flower, tinctures, oils, seeds, and beverages.

For further information please contact:

CEO, Mazen Haddad, ,

President, John McMullen, ,

Investor Relations, Dave Burwell, ,

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

EN
05/04/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Knowlton Capital

 PRESS RELEASE

LGC Capital Ltd. Announces Name Change to Elixxer Ltd.

LGC Capital Ltd. Announces Name Change to Elixxer Ltd. MONTRÉAL, July 30, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that the TSX Venture Exchange (the “TSX-V”) has conditionally approved the change of name of the Corporation to Elixxer Ltd.  The name change was approved by the Corporation’s shareholders at the annual and special meeting held on May 22, 2019 (see press release dated May 23, 2019). The Corporation expects the name change to become effective at the opening of markets on Tuesday, August 6, 2019.  The Corporation will trade und...

 PRESS RELEASE

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval MONTREAL, July 24, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) LGC is pleased to announce that Evolution BNK’s Italian certifying consultants Studio Sannino S.a.s  have advised that Evolution BNK has now received its ISO 9001:2015 Certification for Production, processing, marketing of products derived from Industrial hemp for its Pavia facility in Italy. The following certification processes are now proceeding and under review from the relevant authorities: Agricultural sector certificat...

 PRESS RELEASE

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NE...

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). Freia () was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed fo...

 PRESS RELEASE

LGC Capital Ltd. Announces Change in Financial Year-End

LGC Capital Ltd. Announces Change in Financial Year-End MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing its financial year-end to December 31 from its current year-end of September 30.  As a result, LGC will file an additional interim report as at September 30, 2019 and will report audited financial results for a 15-month transition year from October 1, 2018 to December 31, 2019 (with a comparative of the 12 months ended September 30, 2018). Afterwards, LGC will revert to a customary reporting calendar based on...

 PRESS RELEASE

LGC Capital, Ltd., announces Trichomed received its cultivation licens...

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)   LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded  Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec.  As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch